Key result
APC resistance was not associated with myocardial infarction, with a similar prevalence observed in non-anticoagulated MI survivors and controls.
Why the study?
Is APC resistance associated with myocardial infarction?
Case-Control (n=234)
Is APC resistance associated with myocardial infarction?
APC resistance is not associated with myocardial infarction, suggesting it is not a significant risk factor for arterial thromboembolic disease.
Answers are grounded in this paper and cite their sources.
No support for APC resistance testing in MI evaluation; leaves open its role in venous thromboembolism.
Resistance to activated protein C (APC resistance) due to the factor V mutation 506 Arg-->Gln (factor V Leiden) is the most prevalent inherited risk factor for venous thromboembolism. Its association with arterial thromboembolic disease, however, is still controversial. In the present study we found no difference between the prevalence of APC resistance (assessed by the ratio of the aPTT with and without added APC) in 134 non-anticoagulated survivors of myocardial infarction and that in 100 controls of similar age and sex distribution (2.2% and 2.0%, respectively). Patients showed a significantly higher median value for the aPTT ratio than controls (2.85 and 2.66, respectively), a fact we could not explain by our data.
No takes yet. Share an insight, caveat, or question.
Biasiutti et al. (1995) conducted a case-control in Myocardial infarction (n=234). APC resistance vs. Controls was evaluated on Prevalence of APC resistance. APC resistance was not associated with myocardial infarction, with a similar prevalence observed in non-anticoagulated MI survivors and controls.
Synapse has enriched 10 related papers. Consider them for comparative context: